Covid-19: SEC approves Corbevax for use in kids aged 5-12 years 0 21.04.2022 22:53 Economictimes.indiatimes.com Corbevax is currently being administered to children in the age group 12-14 years. Hyderabad based Biological E had approached the drug regulator earlier this week for granting Emergency Use Authorisation (EUA). However, the SEC sought more data. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
